What it isHIV integrase strand transfer inhibitor; part of a single-tablet regimen.
Why this oneHigh barrier to resistance in a once-daily single tablet with no booster, which is why it is a preferred first-line regimen.
What limits itPolyvalent cations block absorption — separate antacids and supplements. It raises creatinine by inhibiting tubular secretion, without changing GFR.
Molecular structure: Bictegravir
FDA-approved for
HIV infection (2018)
⚠ BOXED WARNING
Severe acute exacerbation of hepatitis B on discontinuation